BR112013031928A2 - derivados de ácido biciclo (3.1.0) hexano-2,6-dicarboxílico como agonistas de receptor de mglu2 - Google Patents
derivados de ácido biciclo (3.1.0) hexano-2,6-dicarboxílico como agonistas de receptor de mglu2Info
- Publication number
- BR112013031928A2 BR112013031928A2 BR112013031928A BR112013031928A BR112013031928A2 BR 112013031928 A2 BR112013031928 A2 BR 112013031928A2 BR 112013031928 A BR112013031928 A BR 112013031928A BR 112013031928 A BR112013031928 A BR 112013031928A BR 112013031928 A2 BR112013031928 A2 BR 112013031928A2
- Authority
- BR
- Brazil
- Prior art keywords
- bicyclo
- hexane
- dicarboxylic acid
- acid derivatives
- receptor agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
resumo patente de invenção: "derivados de ácido biciclo (3.1.0) hexano-2,6-dicarboxílico como agonistas de receptor de mglu2". a presente invenção fornece novos agonistas de mglu2 úteis no tratamento de distúrbio bipolar, esquizofrenia, e distúrbio de ansiedade generalizado. 19999687v1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11382208 | 2011-06-17 | ||
EP11382208.4 | 2011-06-17 | ||
US201161522791P | 2011-08-12 | 2011-08-12 | |
US61/522,791 | 2011-08-12 | ||
PCT/US2012/041229 WO2012173850A1 (en) | 2011-06-17 | 2012-06-07 | Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mglu2 receptor agonist |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013031928A2 true BR112013031928A2 (pt) | 2016-12-13 |
BR112013031928B1 BR112013031928B1 (pt) | 2022-05-24 |
Family
ID=47357416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013031928-3A BR112013031928B1 (pt) | 2011-06-17 | 2012-06-07 | Derivados de ácido biciclo (3.1.0) hexano-2,6-dicarboxílico, seu uso, e composição farmacêutica |
Country Status (20)
Country | Link |
---|---|
US (1) | US9296710B2 (pt) |
EP (1) | EP2721012B1 (pt) |
JP (1) | JP5945592B2 (pt) |
KR (1) | KR101598679B1 (pt) |
CN (1) | CN103596933B (pt) |
AU (1) | AU2012271024B2 (pt) |
BR (1) | BR112013031928B1 (pt) |
CA (1) | CA2836485C (pt) |
CY (1) | CY1117682T1 (pt) |
DK (1) | DK2721012T3 (pt) |
EA (1) | EA023553B1 (pt) |
ES (1) | ES2587204T3 (pt) |
HR (1) | HRP20160676T1 (pt) |
HU (1) | HUE030171T2 (pt) |
MX (1) | MX2013014802A (pt) |
PL (1) | PL2721012T3 (pt) |
PT (1) | PT2721012T (pt) |
RS (1) | RS54888B1 (pt) |
SI (1) | SI2721012T1 (pt) |
WO (1) | WO2012173850A1 (pt) |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993006127A1 (en) | 1991-09-17 | 1993-04-01 | Warner-Lambert Company | Novel amino acid prodrug renin inhibitors |
US5576323A (en) | 1993-12-03 | 1996-11-19 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US5849525A (en) | 1994-03-09 | 1998-12-15 | Brigham And Women's Hospital, Inc. | Compositions corresponding to a proton-coupled peptide transporter and methods of making and using same |
GB9605429D0 (en) * | 1995-11-16 | 1996-05-15 | Lilly Co Eli | Excitatory amino acid receptor antagonists |
NZ323205A (en) | 1995-11-16 | 1999-06-29 | Lilly Co Eli | Excitatory amino acid derivatives |
US5688826A (en) | 1995-11-16 | 1997-11-18 | Eli Lilly And Company | Excitatory amino acid derivatives |
US5952294A (en) | 1996-07-31 | 1999-09-14 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Peptidyl prodrugs and methods of making and using the same |
ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
CN1182105C (zh) | 1998-01-28 | 2004-12-29 | 大正制药株式会社 | 含氟氨基酸衍生物 |
ATE269293T1 (de) | 1998-08-31 | 2004-07-15 | Taisho Pharmaceutical Co Ltd | 6-fluoro(3.1.0)hexan-derivate |
US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
US6770676B2 (en) | 2000-06-28 | 2004-08-03 | Taisho Pharmaceutical Co., Ltd. | Dicarboxylic acid derivatives |
NZ526050A (en) | 2001-01-11 | 2005-03-24 | Lilly Co Eli | Prodrugs of excitatory amino acids |
WO2002055485A1 (en) | 2001-01-11 | 2002-07-18 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
WO2002068380A1 (en) * | 2001-02-22 | 2002-09-06 | Eli Lilly And Company | Synthetic excitatory amino acids |
JP2005505506A (ja) | 2001-06-12 | 2005-02-24 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病の治療に有用な大環状分子 |
NZ533699A (en) | 2001-12-27 | 2006-05-26 | Taisho Pharmaceutical Co Ltd | 6-fluorobicyclo[3.1.0]hexane derivatives |
US20050192273A1 (en) | 2002-04-03 | 2005-09-01 | Johnson Bryan G. | Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
WO2003084610A1 (en) | 2002-04-03 | 2003-10-16 | Eli Lilly And Company | Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
NZ536459A (en) | 2002-06-11 | 2008-03-28 | Lilly Co Eli | Prodrugs of excitatory amino acids |
CN100482680C (zh) * | 2002-06-11 | 2009-04-29 | 伊莱利利公司 | 兴奋性氨基酸前药 |
CN100582087C (zh) * | 2003-06-26 | 2010-01-20 | 大正制药株式会社 | 2-氨基-双环[3.1.0]己烷-2,6-二甲酸酯衍生物 |
WO2005000790A1 (ja) * | 2003-06-26 | 2005-01-06 | Taisho Pharmaceutical Co., Ltd. | 2-アミノビシクロ[3.1.0]ヘキサン-2,6-ジカルボン酸誘導体 |
HUE033352T2 (en) * | 2009-11-18 | 2017-11-28 | Suven Life Sciences Ltd | Bicyclic compounds as alpha4-beta2 nicotinic acetylcholine receptor ligands |
JO2978B1 (en) * | 2009-12-21 | 2016-03-15 | ايلي ليلي اند كومباني | MGLU2 aids |
-
2012
- 2012-06-07 RS RS20160491A patent/RS54888B1/sr unknown
- 2012-06-07 BR BR112013031928-3A patent/BR112013031928B1/pt active IP Right Grant
- 2012-06-07 WO PCT/US2012/041229 patent/WO2012173850A1/en active Application Filing
- 2012-06-07 PT PT127297695T patent/PT2721012T/pt unknown
- 2012-06-07 HU HUE12729769A patent/HUE030171T2/en unknown
- 2012-06-07 KR KR1020137033028A patent/KR101598679B1/ko active IP Right Grant
- 2012-06-07 US US14/123,768 patent/US9296710B2/en active Active
- 2012-06-07 DK DK12729769.5T patent/DK2721012T3/en active
- 2012-06-07 CN CN201280029080.2A patent/CN103596933B/zh active Active
- 2012-06-07 EP EP12729769.5A patent/EP2721012B1/en active Active
- 2012-06-07 AU AU2012271024A patent/AU2012271024B2/en active Active
- 2012-06-07 CA CA2836485A patent/CA2836485C/en active Active
- 2012-06-07 PL PL12729769T patent/PL2721012T3/pl unknown
- 2012-06-07 ES ES12729769.5T patent/ES2587204T3/es active Active
- 2012-06-07 EA EA201391700A patent/EA023553B1/ru not_active IP Right Cessation
- 2012-06-07 SI SI201230569A patent/SI2721012T1/sl unknown
- 2012-06-07 MX MX2013014802A patent/MX2013014802A/es active IP Right Grant
- 2012-06-07 JP JP2014515878A patent/JP5945592B2/ja active Active
-
2016
- 2016-06-14 HR HRP20160676TT patent/HRP20160676T1/hr unknown
- 2016-06-24 CY CY20161100570T patent/CY1117682T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EA201391700A1 (ru) | 2014-04-30 |
KR101598679B1 (ko) | 2016-02-29 |
JP5945592B2 (ja) | 2016-07-05 |
EP2721012B1 (en) | 2016-05-25 |
CA2836485A1 (en) | 2012-12-20 |
SI2721012T1 (sl) | 2016-08-31 |
HRP20160676T1 (hr) | 2016-07-15 |
HUE030171T2 (en) | 2017-05-29 |
PT2721012T (pt) | 2016-07-27 |
RS54888B1 (sr) | 2016-10-31 |
PL2721012T3 (pl) | 2017-05-31 |
US9296710B2 (en) | 2016-03-29 |
MX2013014802A (es) | 2014-01-24 |
EP2721012A1 (en) | 2014-04-23 |
CN103596933B (zh) | 2016-03-23 |
AU2012271024A1 (en) | 2013-11-21 |
ES2587204T3 (es) | 2016-10-21 |
BR112013031928B1 (pt) | 2022-05-24 |
US20140113944A1 (en) | 2014-04-24 |
AU2012271024B2 (en) | 2015-07-09 |
KR20140009568A (ko) | 2014-01-22 |
DK2721012T3 (en) | 2016-08-15 |
JP2014517035A (ja) | 2014-07-17 |
CY1117682T1 (el) | 2017-05-17 |
WO2012173850A1 (en) | 2012-12-20 |
EA023553B1 (ru) | 2016-06-30 |
CN103596933A (zh) | 2014-02-19 |
CA2836485C (en) | 2016-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014029454A2 (pt) | síntese de pirrolo [2,3-b] piridinas | |
BR112013027500A2 (pt) | liberação controlada de imunossupressores de nanotransportadores sintéticos | |
NZ702663A (en) | Nuclear transport modulators and uses thereof | |
CL2012001673A1 (es) | Compuestos derivados de benzamida sustituidos, como moduladores de taar; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de la depresión, trastornos de ansiedad, trastorno bipolar, esquizofrenia, epilepsia, migraña, enfermedad de alzheimer, trastornos metabolicos, entre otras. | |
ECSP12011989A (es) | Agonistas de mglu2 | |
DOP2014000114A (es) | Nuevos 2hindazoles como antagonistas del receptor ep2 | |
CO7350640A2 (es) | Compuestos diméricos | |
IN2014MN01892A (pt) | ||
BR112014005935A2 (pt) | derivados de anilina, sua preparação e sua aplicação terapêutica | |
PH12016501863A1 (en) | Heteroaromatic compounds and their use as dopamine d1 ligands | |
DOP2013000305A (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
PH12016501993A1 (en) | Heteroaromatic compounds and their use as dopamine d1 ligands | |
BR112013031928A2 (pt) | derivados de ácido biciclo (3.1.0) hexano-2,6-dicarboxílico como agonistas de receptor de mglu2 | |
CU20140058A7 (es) | Nuevos 2h-indizoles como antagonistas del receptor ep-2 | |
MX2015008454A (es) | Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos. | |
TN2013000503A1 (en) | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | |
BR112015001515A2 (pt) | compostos terapêuticos | |
UA82244U (ru) | Способ получения вещества с потенциальными физиологическими свойствами -1-(1',1'-дифтор-2'-бром-2'-хлорэтил)-бензимидазол | |
UA72827U (ru) | Способ лечения гипертонической болезни у лиц пожилого возраста | |
UY33560A (es) | Compuestos heterociclicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/06/2012, OBSERVADAS AS CONDICOES LEGAIS |